Table 2 Correlation of AOC4P expression with clinicopathological characteristics in 70 EOC patients
Variable | Low AOC4P expression (n = 35) | High AOC4P expression (n = 35) | P-value |
|---|---|---|---|
n(%) | n(%) | ||
Age (years) | |||
  < 50 | 14 (40.0) | 10 (28.6) |  |
  ≥ 50 | 21 (60.0) | 25 (71.4) | 0.314 |
Histological subtype | |||
 Serous | 26 (80.0) | 23 (62.9) |  |
 Others | 9 (20.0) | 12 (37.1) | 0.434 |
FIGO Stage | |||
 I-II | 2 (5.7) | 8 (22.9) |  |
 III-IV | 33 (94.3) | 27 (77.1) | 0.040 |
Residual tumour diameter (cm) | |||
  < 1 | 32 (91.4) | 28 (80.0) |  |
  ≥ 1 | 3 (8.6) | 7 (20.0) | 0.172 |
Lymph node metastasis | |||
 Absent | 7 (20.0) | 27 (77.1) |  |
 Present | 28 (80.0) | 8 (22.9) | < 0.001 |
CA125 level (U/ml) | |||
  < 600 | 10 (28.6) | 12 (34.3) |  |
  ≥ 600 | 25 (71.4) | 23 (65.7) | 0.607 |
Ascites | |||
  < 100 | 19 (54.3) | 24 (68.6) |  |
  ≥ 100 | 16 (45.7) | 11 (31.4) | 0.220 |